Barr Plans Move To OTC Market With Plan B Emergency Contraceptive
This article was originally published in The Tan Sheet
Executive Summary
Barr Laboratories will continue to pursue an Rx-to-OTC switch for the emergency contraceptive Plan B following its planned acquisition of the product
You may also be interested in...
Dual Status Rx/OTC Plan B In The Works? Barr Weighs Its Options
Barr hinted that it is leaning toward a dual label Rx/OTC approach in seeking FDA approval to switch the Plan B "morning after" pill
Dual Status Rx/OTC Plan B In The Works? Barr Weighs Its Options
Barr hinted that it is leaning toward a dual label Rx/OTC approach in seeking FDA approval to switch the Plan B "morning after" pill
Dual Status Rx/OTC Plan B In The Works? Barr Weighs Its Options
Barr hinted that it is leaning toward a dual label Rx/OTC approach in seeking FDA approval to switch the Plan B "morning after" pill